FDA Inspection 1247521 — Amani A. Fawzi, M.D.
The FDA completed an inspection of Amani A. Fawzi, M.D. on Aug 13, 2024 in Chicago, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Aug 13, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Chicago, IL (United States)
Additional details
Clinical Investigator (CI)